Catyalyst Pharma (CPRX) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.36 -0.03%
Revenue Growth %: +5.9%
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +5.9%
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Carvana (CVNA) PT Lowered to $85 at RBC Capital
- Aspire Biopharma to acquire automotive supplier for $30 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
